Get Level 2

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Imperial Innovations Group Share Price
  4. Imperial Innovations Group Share Regulatory News
  5. Replacement Director's share purchase

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

Imperial Innovations Group Information
  • There is currently no data for IVO

Replacement Director's share purchase

25 Nov 2014 10:45

RNS Number : 9195X
Imperial Innovations Group plc
25 November 2014
 



 

The headline for the Imperial Innovations Group plc announcement released on 24 November 2014 at 16:20 under RNS No 8561X should read

 

Director's share purchase

 

The announcement text headline has been amended to reflect this change and all other details remain unchanged.

 

24 November 2014

 

Imperial Innovations Group plc

 

Director's share purchase

 

Imperial Innovations Group plc (AIM: IVO, "Innovations", "the Group") has been informed today that Peter Chambré, a non-executive director of the Group, has today purchased 3,000 ordinary shares of 3 and 1/33 pence each in the capital of the Group at an average price of 455 pence per share.

 

Following this purchase, Mr Chambré's total holding in the capital of the Group is 3,000 ordinary shares representing approximately 0.002 % of the Group's total issued voting share capital.

 

For further information please contact:

 

Imperial Innovations Group plc

020 3053 8859

Martin Knight, Chairman

William Rayner, Company Secretary

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Mel Toyne-Sewell

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Andy Roberts/Christopher Golden

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMMZMGKNGDZM
234567891011
Date   Source Headline
30th May 20147:00 amRNSVeryan announces results on two-year Mimics study
22nd May 20147:00 amRNSYoyo closes £2.8 million seed investment round
6th May 20142:45 pmRNSHolding(s) in Company
24th Apr 20147:00 amRNSNexeon completes manufacturing facility
14th Apr 201412:00 pmRNSDirector change
3rd Apr 20143:36 pmRNSDirector's share purchase
28th Mar 20147:01 amRNSHalf Yearly Report
13th Mar 20141:04 pmRNSNotice of Results
13th Mar 20147:01 amRNSCircassia announces offer price
26th Feb 20147:40 amRNSCircassia indicative pricing notification
6th Feb 20147:03 amRNSCircassia announces intention to float
28th Jan 20147:00 amRNSAppointment of Joint Broker
7th Jan 20147:00 amRNSCell Medica achieves EU orphan drug designation
30th Dec 201310:00 amRNSFurther investment in TopiVert
18th Dec 20137:00 amRNS£5.1m funding round for Econic Technologies
17th Dec 201312:32 pmRNSResult of AGM
17th Dec 20139:00 amRNS£17.5m funding round for Crescendo Biologics
11th Dec 20137:00 amRNSIXICO launches first CE marked device
10th Dec 20137:00 amRNSSeed funding round for Cambridge spinout Aqdot
6th Dec 20137:00 amRNSGrant of share options
22nd Nov 20133:24 pmRNSOxford Immunotec trading commences on NASDAQ
20th Nov 20139:25 amRNSPulmocide receives £17m Series A funding
18th Nov 20137:00 amRNSMISSION Therapeutics receives £20m funding
16th Oct 20137:01 amRNSOxford Immunotec makes public S1 for potential IPO
16th Oct 20137:00 amRNSBoard Changes
16th Oct 20137:00 amRNSFinal Results
1st Oct 20139:00 amRNSCircassia grass allergy treatment success
26th Sep 20137:00 amRNSCell Medica opens commercial facility in Germany
23rd Sep 20137:05 amRNSIXICO expands into digital healthcare
23rd Sep 20137:00 amRNSProposed acquisition of IXICO Limited
20th Sep 20139:00 amRNSNotice of Results
12th Sep 20137:00 amRNSCircassia phase II clinical study success
10th Sep 20137:00 amRNSLeads £8m funding round in Plaxica
29th Aug 20137:00 amRNSInvestment in new mobile payments business
12th Aug 20136:01 pmRNSDirector/PDMR Shareholding
26th Jul 20138:45 amRNSPortfolio company PolyTherics merges with Antitope
17th Jul 20137:00 amRNSDirectorate Change
2nd Jul 20137:00 amRNS£30m loan from EIB for healthcare investment
25th Jun 20137:00 amRNSInvestment in PsychologyOnline
4th Jun 20137:00 amRNSAutifony starts phase I trial
8th May 20137:00 amRNSCell Medica treats first patient in new trial
29th Apr 20137:00 amRNSInvestment team appointment
17th Apr 20139:26 amRNSBoard change
22nd Mar 20137:00 amRNSHalf year results
1st Mar 20139:22 amRNSNotice of Results
1st Mar 20138:38 amRNSNotification of major interest in shares
25th Feb 20137:00 amRNSCircassia's cat allergy treatment
14th Feb 20137:00 amRNSInvestment in new technology company
23rd Jan 20137:00 amRNS£1.5m investment in new software portfolio company
21st Jan 20133:45 pmRNSListing of shares
234567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IVO
Imperial Innovations Group
LSE
0.00%
BHGG
BHGG.L
LSE
0.00%
JEMI
Jpmorgan Emgdi
LSE
0.00%
TUN
Tungsten west
LSE
-3.30%
CIU
CIU.L
LSE
0.00%
Trending
LLOY
Lloyds
LSE
-2.94%
TRP
Tower Resources
LSE
0.00%
GGP
Greatland Resources
LSE
-6.98%
PLSR
Pulsar Helium
LSE
-3.32%
SML
Strategic Minerals
LSE
-3.70%